Tonix Pharmaceuticals 获纳斯达克批准,将从纳斯达克资本市场转板至纳斯达克全球精选市场

美股速递
Mar 03

Tonix Pharmaceuticals Holding Co (TNXP) 已正式获得纳斯达克交易所的批准,将其普通股的上市资格从纳斯达克资本市场转移至纳斯达克全球精选市场。

此次转板标志着公司达到了更高的上市标准,通常意味着更强的财务表现和更严格的治理要求。这一变动预计将提升公司在全球投资者中的知名度和吸引力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10